Literature DB >> 26399457

miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.

Bianca C Bernardo1, Jenny Y Y Ooi1, Ruby C Y Lin2,3, Julie R McMullen1,4.   

Abstract

miRNAs are small non-coding RNAs (ncRNAs), which regulate gene expression. Here, the authors describe the contribution of miRNAs to cardiac biology and disease. They discuss various strategies for manipulating miRNA activity including antisense oligonucleotides (antimiRs, blockmiRs), mimics, miRNA sponges, Tough Decoys and miRNA mowers. They review developments in chemistries (e.g., locked nucleic acid) and modifications (sugar, 'ZEN', peptide nucleic acids) and miRNA delivery tools (viral vectors, liposomes, nanoparticles, pHLIP). They summarize potential miRNA therapeutic targets for heart disease based on preclinical studies. Finally, the authors review current progress of miRNA therapeutics in clinical development for HCV and cancer, and discuss challenges that will need to be overcome for similar therapies to enter the clinic for patients with cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26399457     DOI: 10.4155/fmc.15.107

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  76 in total

1.  Noncoding RNAs regulating cardiac muscle mass.

Authors:  Glenn D Wadley; Séverine Lamon; Sarah E Alexander; Julie R McMullen; Bianca C Bernardo
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

2.  Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.

Authors:  Bianca C Bernardo; Jenny Y Y Ooi; Aya Matsumoto; Yow Keat Tham; Saloni Singla; Helen Kiriazis; Natalie L Patterson; Junichi Sadoshima; Susanna Obad; Ruby C Y Lin; Julie R McMullen
Journal:  J Physiol       Date:  2016-07-20       Impact factor: 5.182

3.  Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player.

Authors:  Jenny Y Y Ooi; Bianca C Bernardo; Julie R McMullen
Journal:  Ann Transl Med       Date:  2016-12

4.  Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.

Authors:  Shenglong Li; Yi Pei; Wei Wang; Fei Liu; Ke Zheng; Xiaojing Zhang
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

5.  Circ-0001313/miRNA-510-5p/AKT2 axis promotes the development and progression of colon cancer.

Authors:  Fang-Ling Tu; Xi-Qing Guo; Hai-Xia Wu; Zhi-Yun He; Fang Wang; Ai-Jun Sun; Xu-Dong Dai
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

6.  MiR-20 regulates myocardiac ischemia by targeting KATP subunit Kir6.1.

Authors:  Li Nie; Ya-Nan Zhao; Hong-Yan Luo; Xin-Wu Hu; Liang-Pin Zhang; Hua-Min Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

7.  The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.

Authors:  Qian Ding; Yi-Zhun Zhu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.

Authors:  Jenny Y Y Ooi; Bianca C Bernardo; Saloni Singla; Natalie L Patterson; Ruby C Y Lin; Julie R McMullen
Journal:  RNA Biol       Date:  2016-04-28       Impact factor: 4.652

Review 9.  From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure.

Authors:  Bianca C Bernardo; Burns C Blaxall
Journal:  Heart Lung Circ       Date:  2016-01-19       Impact factor: 2.975

10.  Pleiotropic Locus 15q24.1 Reveals a Gender-Specific Association with Neovascular but Not Atrophic Age-Related Macular Degeneration (AMD).

Authors:  Christina Kiel; Tobias Strunz; Felix Grassmann; Bernhard H F Weber
Journal:  Cells       Date:  2020-10-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.